Search Within

Sarat Chandarlapaty

  1. "Lillian Smyth"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (5)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (14)
  2. Breast Medicine Service (14)
  3. Department of Medicine (14)
  4. GSK Faculty (14)
  5. Human Oncology and Pathogenesis Program (14)
  6. Solid Tumor Oncology Division (14)

More Groups

People
  1. Lillian Smyth (14)
  2. Jose Baselga (12)
  3. David Hyman (9)
  4. Barry Taylor (7)
  5. Clifford Hudis (6)
  6. David Solit (6)

More People

Years
  1. 2021 (3)
  2. 2020 (3)
  3. 2019 (1)
  4. 2018 (3)
  5. 2017 (1)
  6. 2016 (2)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Cancer Research (2)
  3. Breast Cancer Research and Treatment (1)
  4. Cancer Cell (1)
  5. Cancer Discovery (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. American Association for Cancer Research (4)
  3. Nature Publishing Group (2)
  4. Cell Press (1)
  5. Oxford University Press (1)
  6. Springer (1)

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
    Journal Article

    Brannon, A. R.; Jayakumaran, G.; Diosdado, M.; Patel, J.; Razumova, A.; Hu, Y.; Meng, F.; Haque, M.; Sadowska, J.; Murphy, B. J.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Utility of serial cfDNA NGS for prospective genomic analysis of patients on a phase I basket study
    Journal Article

    Smyth, L. M.; Reichel, J. B.; Tang, J.; Patel, J. A. A.; Meng, F.; Selcuklu, D. S.; Houck-Loomis, B.; You, D.; Samoila, A.; Schiavon, G.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer
    Journal Article

    Smyth, L. M.; Batist, G.; Meric-Bernstam, F.; Kabos, P.; Spanggaard, I.; Lluch, A.; Jhaveri, K.; Varga, A.; Wong, A.; Schram, A. M.; more...
    npj Breast Cancer (2021)

    Fulltext@MSK | Save
  • Capivasertib, an AKT kinase inhibitor, as monotherapy or in combination with fulvestrant in patients with AKT1(E17K)-mutant, ER-positive metastatic breast cancer
    Journal Article

    Smyth, L. M.; Tamura, K.; Oliveira, M.; Ciruelos, E. M.; Mayer, I. A.; Sablin, M. P.; Biganzoli, L.; Ambrose, H. J.; Ashton, J.; Barnicle, A.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Capivasertib (AZD5363) in combination with fulvestrant in PTEN-mutant ER+ metastatic breast cancer
    Meeting Abstract

    Smyth, L. M.; Batist, G.; Meric-Bernstam, F.; Kabos, P.; Spanggaard, I.; Lluch, A.; Schram, A.; Varga, A.; Wong, A.; Ambrose, H.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Efficacy and determinants of response to HER kinase inhibition in HER2-mutant metastatic breast cancer
    Journal Article

    Smyth, L. M.; Piha-Paul, S. A.; Won, H. H.; Schram, A. M.; Saura, C.; Loi, S.; Lu, J.; Shapiro, G. I.; Juric, D.; Mayer, I. A.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with human epidermal growth receptor 2 overexpressing metastatic breast cancer: 5-year follow-up
    Journal Article

    Wang, R.; Smyth, L. M.; Iyengar, N.; Chandarlapaty, S.; Modi, S.; Jochelson, M.; Patil, S.; Norton, L.; Hudis, C. A.; Dang, C. T.
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Longer follow-up on clinical outcomes of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2 overexpressing metastatic breast cancer
    Meeting Abstract

    Wang, R.; Smyth, L. M.; Iyengar, N. M.; Modi, S.; Chandarlapaty, S.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The genomic landscape of endocrine-resistant advanced breast cancers
    Journal Article

    Razavi, P.; Chang, M. T.; Xu, G.; Bandlamudi, C.; Ross, D. S.; Vasan, N.; Cai, Y.; Bielski, C. M.; Donoghue, M. T. A.; Jonsson, P.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • AZD5363 in combination with fulvestrant in AKT1-mutant ER-positive metastatic breast cancer
    Meeting Abstract

    Smyth, L. M.; Oliveira, M.; Ciruelos, E.; Tamura, K.; El-Khoueiry, A.; Mita, A.; You, B.; Renouf, D. J.; Sablin, M. P.; Lluch, A.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save